Search Results

The Cora Microcatheters are intended to be used in conjunction with steerable guidewires to access discrete regions of the coronary and peripheral vasculature. They may be used to facilitate placement and exchange of guidewires and other interventional devices and provide a conduit for the delivery of saline solutions of diagnostic contrast.

The CoraFlex and CoraForce Microcatheters (Cora Microcatheters) are single lumen catheters designed to access the peripheral and coronary vasculature. Each configuration has a hydrophilic coated coiled catheter with a braided support matrix, radiopaque distal tip, proximal luer, and "spin-friendly" strain relief. The Cora Microcatheters will also allow for the exchange of guidewires and provide a conduit for delivery diagnostic or therapeutic agents.

This document is a 510(k) clearance letter for medical microcatheters, not an AI/ML device. Therefore, the requested information about acceptance criteria, study data, ground truth, and expert involvement for AI device performance is not applicable to this submission.

The FDA clearance is based on non-clinical (bench) testing demonstrating substantial equivalence to a predicate device, as indicated by the following sections:

1. A table of acceptance criteria and the reported device performance:
This information is not provided in a table format. The document states:
"The Cora Microcatheters met all specified criteria and did not raise new questions regarding safety and effectiveness compared to the predicate."
And
"Based on the performance testing, the Cora Microcatheters were found to be substantially equivalent to the predicate."

The specific criteria and direct performance metrics are not detailed in this summary, but the types of tests performed indicate the areas of performance evaluated:

• Simulated Use
• Dimensional Verification
• Radiopacity
• Leak Testing
• Kink Resistance
• Corrosion Resistance
• Component Integrity
• Bond Integrity
• Particulate Testing
• Torque Testing
• Burst Testing
• Lubricity and Coating Integrity Testing
• Design Validation/Usability
• Sterility Testing
• Biocompatibility Assessment

2. Sample size used for the test set and the data provenance (e.g., country of origin of the data, retrospective or prospective):
This information is not explicitly stated in the provided document. The study was non-clinical (bench testing).

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts:
Not applicable, as this is a non-clinical device clearance.

4. Adjudication method (e.g., 2+1, 3+1, none) for the test set:
Not applicable, as this is a non-clinical device clearance.

5. If a multi-reader, multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance:
Not applicable, as this is a non-clinical device clearance and does not involve AI or human readers.

6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done:
Not applicable, as this is a non-clinical device clearance and does not involve an algorithm.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.):
Not applicable. The "ground truth" for this device would be established by engineering specifications and industry standards for medical device performance, as evaluated through bench testing.

8. The sample size for the training set:
Not applicable, as this is a non-clinical device and does not involve a training set as in AI/ML.

9. How the ground truth for the training set was established:
Not applicable, as this is a non-clinical device and does not involve a training set as in AI/ML.

Ask a specific question about this device

The Delivery Catheter is indicated for the introduction of pacing and defibrillation leads to the right heart, inclusive of the Left Bundle Branch Area.

The subject Delivery Catheter (CPS Locator 3D Delivery Catheter) is a single-use percutaneous catheter intended for venous introduction of pacing or defibrillation leads.

The subject Delivery Catheter is packaged with a dilator for introduction into the vasculature. Proximally, the subject Delivery Catheter is equipped with a hemostatic valve, and the distal soft, rounded, radiopaque tip facilitates imaging under fluoroscopy. The subject Delivery Catheter is designed to be slittable, thereby allowing its removal after device placement. A variety of curves and lengths are available to accommodate various anatomies and different locations.

This FDA 510(k) clearance letter pertains to a medical device, not an AI/ML software. Therefore, the detailed acceptance criteria and study information requested, which are typical for AI/ML device evaluations, are not applicable in this context.

The document discusses the CPS Locator 3D Delivery Catheter, a physical medical device. The 510(k) process for such devices focuses on demonstrating substantial equivalence to a legally marketed predicate device, primarily through performance testing (bench testing, biocompatibility, sterilization, etc.) and, in this case, some real-world usage data. It does not involve AI/ML performance metrics like sensitivity, specificity, or ground truth established by expert consensus for diagnostic accuracy.

Here's a breakdown of why many of your requested points are not applicable, followed by the information that can be extracted:

• Acceptance Criteria Table & Reported Performance: Not available in an AI/ML context. The document focuses on demonstrating the device's functional integrity and equivalence to a predicate.
• Sample Size (Test Set) & Data Provenance: Not applicable for an AI/ML test set. The clinical data mentioned is retrospective/real-world observational data on the previously cleared device.
• Number of Experts & Qualifications (Ground Truth): Not applicable as there's no diagnostic AI/ML algorithm requiring ground truth establishment by experts.
• Adjudication Method: Not applicable.
• MRMC Comparative Effectiveness Study: Not applicable.
• Standalone Performance: Not applicable as it's a physical catheter, not an AI/ML algorithm.
• Type of Ground Truth: Not applicable. The "ground truth" for a physical device is its functional performance and safety during use.
• Sample Size (Training Set): Not applicable as there's no AI/ML model to train.
• How Ground Truth for Training Set was Established: Not applicable.

Information that can be extracted from the provided document regarding the CPS Locator 3D Delivery Catheter:

The document describes the acceptance criteria and study to demonstrate substantial equivalence for a physical medical device, not an AI/ML system. Therefore, many of the requested fields related to AI/ML software evaluation are not directly applicable.

Here's a summary of the relevant information provided:

1. A table of acceptance criteria and the reported device performance

2. Sample size used for the test set and the data provenance

• Test Set (Bench/Performance Testing): Not explicitly stated as a separate "test set" for the new submission, but the document mentions "All testing was performed on test units representative of finished devices." The specific number of units for each bench test is not provided in this summary.
• Clinical Data (Real-World Evidence):
  • Post-market study: Data collected from 42 physicians at multiple US centers.
  • Retrospective Observational Study 1: Not explicitly stated sample size, but mentioned "patients."
  • Retrospective Observational Study 2: 66 patients.
  • HeartRhythm Publication: 8 patients.
• Data Provenance: Primarily United States (US) centers. The data is described as post-market, real-world observational, and retrospective from the previously cleared predicate device (K230363).

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

• Not Applicable. This is a physical medical device clearance, not an AI/ML diagnostic device requiring expert-established ground truth for performance metrics like sensitivity/specificity. The "ground truth" for the clinical data related to lead delivery success was based on actual surgical outcomes reported by physicians.

4. Adjudication method for the test set

• Not Applicable. No expert adjudication for an AI/ML algorithm's output was performed.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

• Not Applicable. This is a physical medical device, not an AI/ML system.

6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

• Not Applicable. This is a physical medical device.

7. The type of ground truth used

• For the clinical data, the "ground truth" was based on observed clinical outcomes (e.g., successful lead delivery, achievement of LBBAP, reported complications/adverse events) as documented and reported by treating physicians and study investigators. This is akin to patient outcomes data in real-world settings.

8. The sample size for the training set

• Not Applicable. There is no AI/ML algorithm with a training set.

9. How the ground truth for the training set was established

• Not Applicable. There is no AI/ML algorithm with a training set.

Ask a specific question about this device

The Guiding Catheter is designed to provide a pathway through which therapeutic and diagnostic devices are introduced. The Guiding Catheter is intended to be used in the coronary or peripheral vascular system.

The Hydrophilic Guiding Catheter consists of a reinforced body with a hub and strain relief at the proximal end and an intermediate and soft tip at the distal end. The distal part of the catheter features a specific tip shape. A part of the catheter body features a hydrophilic coating. The (distal part of the) catheter body is provided either with or without "in-line" side holes.

The guiding catheter is a flexible plastic tube featuring a luer hub, strain relief, a body, an intermediate tip, and a soft tip. The body and the intermediate tip consist of an inner liner (basecoat) and an outer jacket (topcoat) reinforced with a tightly wound stainless steel braid wire in between the layers. The central lumen of the catheter is used for the percutaneous, transluminal passage and placement of guidewires, diagnostic and therapeutic devices within the vascular system. After the catheter is inserted through the skin using a dilator, a sheath (introducer) and guide wire is brought into position. Subsequently, a guidewire is advanced through its lumen and tracked over by a diagnostic device and/or a therapeutic devices to the intended location. The distal section of the catheters has a variety of preformed shapes (e.g. Judkins Left (abbreviated as JL), Judkins Right (JR), Amplatz (AL), Multi-purpose (MP), hockey stick) to facilitate placement of the catheter tip in the desired target vessel. Some catheter models feature two (2) small "in-line" side holes in the intermediate tip section to maintain perfusion of the target vessel. This device is a single-use device (i.e., single patient, single procedure, single purpose use). After finalizing the procedure, the catheter is withdrawn, removed and discarded.

This document is an FDA 510(k) clearance letter for a medical device, specifically a "Primum Hydrophilic Guiding Catheter." It is NOT about a software-based AI/ML device, and therefore does not contain the information requested in your prompt regarding acceptance criteria, study details, human reader studies, or ground truth for AI models.

The device discussed is a physical catheter, and its acceptance criteria and proof of performance are based on bench testing (biocompatibility, physical properties tests) and comparison to a "predicate" device (another catheter already on the market) that is essentially the same product under a different trade name.

Therefore, I cannot provide the information requested in your prompt related to AI/ML device evaluation, as the provided text describes a traditional medical device clearance.

Ask a specific question about this device

The Delivery Catheter is indicated for the introduction of various types of catheters and pacing or defibrillator leads.

The modified Delivery Catheter (CPS Locator 3D Delivery Catheter) is a single-use percutaneous catheter indicated for the introduction of various types of catheters and pacing or defibrillation leads.

The modified Delivery Catheter is packaged with a dilator for introduction into the vasculature. Proximally, the modified Delivery Catheter is equipped with a hemostatic valve, and the distal soft, rounded, radiopaque tip facilitates imaging under fluoroscopy. The modified Delivery Catheter is designed to be slittable, thereby allowing its removal after device placement. A variety of curves and lengths are available to accommodate various anatomies and different locations.

This document describes the FDA 510(k) clearance for the CPS Locator 3D Plus Delivery Catheter, a medical device. Based on the provided text, the device is a percutaneous catheter used for introducing various types of catheters and pacing or defibrillator leads. The clearance is based on its substantial equivalence to a predicate device (CPS Locator 3D Delivery Catheter, K230363).

However, the provided text does not contain any information about an AI/ML-based device or any study that would typically be described with the requested criteria (e.g., sample sizes, expert adjudication, MRMC studies, ground truth establishment, training sets). The acceptance criteria mentioned are related to engineering and biological performance of a physical medical device (catheter) rather than the performance of an AI/ML algorithm.

Therefore, I cannot fulfill your request for information related to an AI/ML device's acceptance criteria and study data based on this document. The document describes a traditional medical device clearance, not an AI/ML software clearance.

**If your intention was to ask about the acceptance criteria and supporting studies for a physical medical device as described in the document, here is the information: **

1. Table of Acceptance Criteria and Reported Device Performance:

The document outlines performance tests conducted, implying these tests have acceptance criteria which the device met ("passed the following tests"). Specific quantitative acceptance criteria (e.g., "leak rate must be

Ask a specific question about this device

The CenterFlow Molding Balloon Catheter is intended to assist in the dilatation of self-expanding endoprostheses in large diameter vessels.

The CenterFlow Molding Balloon Catheter is intended to assist in the dilatation of self-expanding endoprostheses in large diameter vessels. When used in its indications for use, it is a low-permissive, over-the-wire, single-use device comprised of two elongated non-compliant nylon balloons that are attached to and within a nitinol support frame. The two elongated balloons are constrained in a zigzag arrangement by the nitinol support frame. Upon inflation, this configuration enables expansion of the device head through balloon straightening, to assist the dilatation of self-expanding endoprostheses in large diameter vessels. Expansion of the zig-zag balloon configuration creates a central orifice permitting maintained hemodynamic flow during the molding procedure. The inflation lumen is 9 Fr and is made of PEBAX 72D. A co-axial PEBAX 72D guidewire lumen runs through the inflation lumen and device head and terminates into a distal polycarbonate tip. Two platinum-iridium markers provide angiographic visualization of the distal and proximal balloon edges to facilitate intravascular balloon placement prior to inflation. The catheter has a working length of 110 cm and it connects proximally to a standard Y-connector at the proximal end. The Y-connector allows for separation of two lumens - an angled luer-lock hub to inflate and deflate the balloon and a straight luer-lock hub which accepts a 0.035" guidewire. The device is deflated and inserted over the guidewire through the hemostasis valve of a transfemoral introducer sheath.

The provided text is a 510(k) premarket notification letter and summary for the CenterFlow Molding Balloon Catheter. This document details the device's intended use, design, and comparison to a predicate device. However, it does not contain any information regarding specific acceptance criteria or a study that proves the device meets those criteria in terms of performance metrics like accuracy, sensitivity, or specificity.

The "Non-Clinical Tests Summary & Conclusions" section lists the types of tests performed (Benchtop performance testing, Biological Safety Evaluation, In vivo safety evaluation, Packaging validation, Shelf-life validation, Usability Engineering evaluation), but it does not provide any quantitative results, acceptance criteria, or details of a study with a test set, ground truth, or expert involvement.

Therefore, I cannot provide the requested information for acceptance criteria and the study that proves the device meets them because the provided text does not contain any of that specific data.

Here’s what I can extract based on the information not present in the document:

1. A table of acceptance criteria and the reported device performance:

   • Acceptance Criteria: Not available in the provided text.
   • Reported Device Performance: Not available in the provided text (beyond a general statement that "the subject device is substantially equivalent to the predicate device" based on non-clinical testing).

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective): Not available for performance testing. (Note: "In vivo safety evaluation" is mentioned, which implies animal or human subjects, but no details on size or provenance are given for performance evaluation.)

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience): Not available.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set: Not available.

5. If a multi reader multi case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This device is a physical catheter, not an AI or imaging diagnostic tool that would involve "human readers" or "AI assistance."

6. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable for this type of medical device.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc): Not available.

8. The sample size for the training set: Not applicable (not an AI/ML device with a training set).

9. How the ground truth for the training set was established: Not applicable.

In summary, the provided FDA 510(k) notification focuses on establishing substantial equivalence based on design features and general non-clinical testing (benchtop, biocompatibility, in vivo safety, etc.) for a physical medical device (balloon catheter), rather than providing detailed performance metrics typically associated with diagnostic or AI-powered devices. The document explicitly states the "Non-Clinical Tests Summary & Conclusions" showed substantial equivalence but does not elaborate on the specific quantifiable results or the methodology behind them.

Ask a specific question about this device

The Delivery Catheter is intended for the venous introduction of pacing or defibrillation leads.

The modified Delivery Catheter (FlexiGo 3D Delivery Catheter) is a single-use percutaneous catheter intended for venous introduction of pacing or defibrillation leads.

The modified Delivery Catheter is packaged with a dilator and two (2) trans vavular introducers for introduction into the vasculature. Proximally, the modified Delivery Catheter is equipped with a hemostatic valve, and the distal soft, rounded, radiopaque tip facilitates imaging under fluoroscopy. The modified Delivery Catheter is designed to be slittable, thereby allowing its removal after device placement. A variety of curves and lengths are available to accommodate various anatomies and different locations.

This document describes the FDA 510(k) Clearance Letter for the "FlexiGo 3D Delivery Catheter." This is a medical device, and the information provided details its intended use, comparison to a predicate device, and the performance data submitted for its clearance. However, the provided document does not contain any information related to an AI/ML (Artificial Intelligence/Machine Learning) device or study.

Therefore, I cannot provide a response that describes "Acceptance Criteria and the Study that Proves the Device Meets the Acceptance Criteria" in the context of an AI/ML device, nor can I fill in a table of acceptance criteria for an AI/ML device or discuss MRMC studies, training/test sets, or ground truth establishment relevant to AI/ML.

The provided text pertains to a traditional medical device (a catheter) and discusses its physical and functional characteristics, material compatibility, and standard medical device performance testing (biocompatibility, sterilization, dimensional verification, etc.).

To address your request, I would need a document describing an AI/ML medical device and its associated clinical study, statistical methodology, and performance metrics relevant to AI/ML algorithm evaluation.

Ask a specific question about this device

Dorado™ PTA Balloon Dilatation Catheter is recommended for Percutaneous Transluminal Angioplasty (PTA) of the renal, iliac, femoral, popliteal, tibial, peroneal, and subclavian arteries and for the treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae. This device is also recommended for post-dilatation of balloon expandable and self expanding stents in the peripheral vasculature. This catheter is not for use in coronary arteries.

The Dorado™ PTA Balloon Dilatation Catheter is a high-performance balloon catheter consisting of an over the wire catheter with a balloon fixed at the distal tip. The proprietary non-compliant, low-profile balloon is designed to provide consistent balloon diameters and lengths even at high pressures. Two radiopaque markers delineate the working length of the balloon and aid in balloon placement. The catheter includes an atraumatic tip to facilitate advancement of the catheter to and through the stenosis. The novel catheter consists of a distal triple lumen and a proximal coaxial lumen and is designed to optimize the balance between pushabilty and trackability. The over the wire catheter is compatible with 0.035" guidewire and is available in 40, 80, 120, and 135 cm working lengths. The proximal portion of the catheter includes a female luer lock hub connected to the inflation lumen, and a female luer-lock hub connected to the guidewire lumen. Packaged with every product is a profile reducing sheath that is positioned over the balloon for protection before use. A re-wrapping tool is also provided on the catheter shaft. A stylet is placed into the tip of the catheter to aid in rewrap/refolding of the balloon. These products are not made with natural rubber latex.

This 510(k) clearance letter is for a medical device (Dorado™ PTA Balloon Dilatation Catheter), not an AI/Software as a Medical Device (SaMD).

Therefore, the information requested in your prompt (e.g., acceptance criteria for AI algorithm performance, sample sizes for test/training sets, expert adjudication, MRMC studies, ground truth establishment) is not applicable to this document.

The document discusses the performance evaluation of a physical medical device, focusing on in vitro pre-clinical testing to demonstrate substantial equivalence to a predicate device. This includes:

• Performance Data: Trackability, Balloon Burst Strength, Balloon Fatigue, Sheath Compatibility, Dimensional Verification, Simulated Use, etc.
• Biocompatibility Testing: Cytotoxicity, Sensitization, Irritation, Systemic Toxicity, Hemocompatibility.

The acceptance criteria for this device would be engineering specifications and safety standards for balloon catheters, not statistical metrics for AI algorithm performance.

In summary, based on the provided document, I cannot answer the questions related to AI/SaMD acceptance criteria and study design. The document describes the clearance of a traditional physical medical device.

Ask a specific question about this device

The GORE® Tri-Lobe Balloon Catheter is intended to assist in the dilatation of self-expanding endoprostheses in large diameter vessels.

The GORE® Tri-Lobe Balloon Catheter is a compliant, tri-lobed polyurethane balloon catheter. The lobed design of the balloon catheter is designed for inflation without complete blockage of aortic blood flow. The three polyurethane balloons are mounted on the leading end of a multi-lumen catheter shaft. Radiopaque markers indicate the balloon edges. Each of the three inflation lumens is in communication with one of the balloons. The inflation port is in communication with all of the inflation lumens and is affixed with a luer lock. The guidewire lumen allows introduction of a 0.035" (0.89 mm) diameter guidewire for over-the-wire access. The trailing end of the guidewire lumen is affixed with a flushing/guidewire port with a luer lock, used for flushing the guidewire lumen. A Tuohy-Borst valve is integrated into the trailing end of the guidewire lumen.

The GORE® Tri-Lobe Balloon Catheter is available in two sizes. The smaller balloon can be inflated to diameters of 16 mm to 32 mm and the larger balloon can be inflated to diameters of 26 mm to 48 mm.

The provided FDA 510(k) clearance letter and associated summary pertain to a medical device, the GORE® Tri-Lobe Balloon Catheter, not an AI/ML-driven software device. Therefore, the information typically requested for AI/ML device acceptance criteria and study design (such as confidence intervals for performance metrics, sample sizes for training/test sets, expert adjudication methods, MRMC studies, or ground truth establishment) is not applicable or present in this document.

The document describes the device's technical characteristics, indications for use, and summaries of performance testing and clinical data to demonstrate substantial equivalence to a predicate device.

Here's a breakdown of the relevant information provided, structured to highlight what is and isn't applicable to your request:

Acceptance Criteria and Device Performance (Not Applicable as per AI/ML context)

While the document details performance testing, it doesn't present a table of quantitative acceptance criteria and corresponding reported device performance values in the way one would for an AI/ML device (e.g., Sensitivity, Specificity thresholds). Instead, safety and effectiveness are demonstrated through various tests and clinical observations.

Table 1. Technological Characteristics (This is a comparison of intended balloon diameters and inflation volumes, not performance metrics like accuracy or sensitivity for an AI/ML device.)

Key observations for performance (qualitative as per the document):

• Clinical Outcomes (Day 0 Adverse Events): Among the 44 subjects with known GORE® Tri-Lobe Balloon Catheter use in the Aortic Arch substudy:
  • Zero (0) Adverse Events of Aortic Rupture, Aortic Dissection, Balloon Related Mortality, and Type III Endoleak.
  • One (1) reported Type I Endoleak at Day 0.
• Conclusion: The device is deemed "substantially equivalent" to its predicate based on bench, pre-clinical, and clinical testing. The changes did not raise new concerns related to safety or effectiveness.

Study Details (Interpreted for a medical device rather than AI/ML)

1. Sample Size Used for the Test Set and Data Provenance:

   • Test Set (Clinical Data): 77 total subjects were treated for lesions of the aortic arch in the GORE® TAG® Thoracic Branch Endoprosthesis Clinical Trial (G130120). Of these, 44 subjects (57.1%) had known use of the GORE® Tri-Lobe Balloon Catheter during the index procedure.
   • Data Provenance: The study was a "prospective, non-randomized, multicenter study." The country of origin is not explicitly stated but implied to be related to FDA clearance (likely US-based).
   • Retrospective/Prospective: Prospective.

2. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications:

   • This is not applicable as this is a medical device study, not an AI/ML performance evaluation requiring expert labeling for ground truth. Clinical outcomes and observations from medical professionals involved in the trial serve as the "ground truth" for device safety and performance here.

3. Adjudication Method for the Test Set:

   • Not applicable in the context of AI/ML ground truth adjudication. Clinical adverse events and outcomes were reported and presumably reviewed as part of the clinical trial protocol.

4. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study was done:

   • No, an MRMC study is relevant for evaluating the impact of AI on human readers' diagnostic performance. This document describes the performance of a physical medical device.

5. If a Standalone (Algorithm Only Without Human-in-the-Loop Performance) was done:

   • Not applicable as this is not an algorithm. The device's performance is inherently linked to its use by medical professionals in a clinical setting ("human-in-the-loop" in a very different sense).

6. The Type of Ground Truth Used:

   • Clinical Outcomes/Events: The "ground truth" for the device's safety and effectiveness was established through direct observation of clinical adverse events (e.g., Aortic Rupture, Aortic Dissection, Type I Endoleak) and the device's ability to facilitate dilatation of endoprostheses during the clinical trial. Bench and In Vivo Animal Testing also contributed to this "ground truth" indirectly by demonstrating physical properties and performance.

7. The Sample Size for the Training Set:

   • Not applicable. This is not an AI/ML device that requires a training set.

8. How the Ground Truth for the Training Set was Established:

   • Not applicable.

In summary, the provided document is a 510(k) clearance letter for a physical medical device. As such, the standard criteria and study designs relevant to AI/ML device performance evaluation (e.g., sensitivity, specificity, expert adjudication, MRMC studies, training/test sets) are not found within this content.

Ask a specific question about this device

The Shockwave CS Guide Catheter is intended to access the coronary venous system and may be used alone (9F) or in a dual catheter delivery (e.g., 9F with 7F). The catheter serves as a conduit for the introduction of interventional/diagnostic devices introduced into the coronary venous system.

The Shockwave CS Guide Catheter is a single lumen catheter consisting of a PTFE liner, stainless steel braid, and polymer outer jacket. The transition segments of the catheter have a gradual decrease in stiffness starting from the proximal shaft segment and ending at the distal tip. The Shockwave CS Guide Catheter features a curved distal shaft with radiopaque tip. The proximal end of the guide catheter has a standard luer fitting for connecting to a hemostasis valve. The proximal luer also includes a curve indicator to match the direction of the guide catheter tip curvature and provides a tactile and visual cue to the user. The Shockwave CS Guide Catheter is provided EO sterile and is for single use only.

The provided FDA 510(k) clearance letter for the Shockwave CS Guide Catheter does not contain the detailed information requested regarding acceptance criteria and the study proving device performance in the context of clinical or AI-assisted diagnostic performance.

The document primarily focuses on:

• Substantial equivalence to a predicate device (Boston Scientific Acuity Pro Lead Delivery System).
• Device description and indications for use.
• Non-clinical bench testing (biocompatibility, design verification, sterilization, packaging) to demonstrate engineering performance and safety.

Therefore, I cannot provide a detailed answer to most of your questions based on the input provided. The document describes a traditional medical device clearance, not one involving software/AI with diagnostic performance studies as would be typical for your detailed request.

However, I can extract the information that is present regarding the non-clinical testing.

Based on the provided 510(k) Summary, here's what can be extracted and what is NOT present:

The device in question, the "Shockwave CS Guide Catheter," is a physical medical device (a catheter) intended for accessing the coronary venous system. The performance testing described in the document is primarily non-clinical bench testing to demonstrate the physical and material properties of the catheter, its safety (biocompatibility, sterility), and its ability to function as intended (e.g., flexibility, torque strength, compatibility).

This type of device clearance typically does not involve human reader studies, AI performance metrics, or complex ground truth establishment as would be seen for diagnostic AI/software devices.

Table of Acceptance Criteria and Reported Device Performance (Based on Non-Clinical Testing):

Information NOT Present in the Document and Why (Context for AI/Diagnostic Devices):

The following points are typically relevant for AI/diagnostic software clearances, but are not applicable or detailed in this 510(k) for a physical medical catheter:

1. Sample sizes used for the test set and the data provenance: Not applicable for a physical device's non-clinical bench testing. Bench tests use defined quantities of devices or materials, not patient data sets.
2. Number of experts used to establish the ground truth for the test set and the qualifications of those experts: Not applicable. Ground truth in this context refers to engineering specifications and performance within a laboratory setting, not clinical diagnostic accuracy.
3. Adjudication method (e.g., 2+1, 3+1, none) for the test set: Not applicable. There's no clinical "test set" requiring human adjudication as understood for AI/diagnostic studies.
4. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance: Not applicable. This device is a catheter, not an AI diagnostic tool.
5. If a standalone (i.e. algorithm only without human-in-the-loop performance) was done: Not applicable. No algorithm involved.
6. The type of ground truth used (expert consensus, pathology, outcomes data, etc.): For this device, "ground truth" equates to engineering specifications, validated test methods (e.g., ISO standards), and pre-defined acceptable ranges for physical properties.
7. The sample size for the training set: Not applicable. This is a physical device, not an AI model requiring a training set.
8. How the ground truth for the training set was established: Not applicable.

In summary: The provided document is a standard 510(k) clearance for a physical medical device. The "acceptance criteria" and "study that proves the device meets the acceptance criteria" refer to a rigorous battery of non-clinical, benchtop engineering tests and biocompatibility assessments, rather than clinical efficacy studies or AI performance evaluations as implied by your detailed request.

Ask a specific question about this device

The APRO 45 Catheter is indicated for use in facilitating the insertion and guidance of appropriately sized interventional devices into a selected blood vessel in the peripheral and neurovascular systems. The APRO 45 Catheter is also indicated for use as a conduit for retrieval devices.

The APRO 45 Catheter is a single-lumen, braid and coil reinforced catheter. The APRO 45 Catheter is designed to facilitate the insertion and guidance of interventional devices into peripheral and neuro vasculature. Using standard catheterization techniques under fluoroscopic guidance, the APRO 45 Catheter is introduced through a guide catheter or guide sheath and over a guidewire into the target vasculature. The distal segment of the catheter shaft has a hydrophilic coating to aid navigation through the vasculature. A radiopaque marker is located at the distal tip of the catheter for visualization under fluoroscopy. The APRO 45 Catheter is provided with an Introducer Sheath. The APRO 45 Catheter contains animal derived materials made from tallow derivatives.

The provided FDA 510(k) clearance letter and summary for the APRO 45 Catheter focuses on demonstrating substantial equivalence to a predicate device through non-clinical performance and biocompatibility testing. It does not present information related to an AI/ML-driven medical device, a multi-reader multi-case (MRMC) study, or acceptance criteria for algorithmic performance.

Therefore, based solely on the provided text, it's not possible to fulfill most of the requested information points, as they pertain to the evaluation of AI/ML diagnostic or assistive devices. The document describes a physical medical device (catheter) and its non-clinical testing.

However, I will extract and present the acceptance criteria and performance information that is available from the provided text, primarily from the "Performance Data" section.

Acceptance Criteria and Device Performance for APRO 45 Catheter

The APRO 45 Catheter is a physical medical device, not an AI/ML driven diagnostic or assistive device. The acceptance criteria and performance data provided in the FDA 510(k) summary pertain to the physical and biological characteristics of the catheter, supporting its substantial equivalence to a predicate device.

1. Table of Acceptance Criteria and Reported Device Performance

Ask a specific question about this device